Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain.

Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain.

Item
http://www.wikidata.org/entity/Q44608425
Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumabT cell activation and differentiation is modulated by a CD6 domain 1 antibody ItolizumabCD6 as a therapeutic target in autoimmune diseases: successes and challenges.Fine mapping and functional analysis of the multiple sclerosis risk gene CD6Poly(I:C) promotes TNFα/TNFR1-dependent oligodendrocyte death in mixed glial cultures.Immunological evaluation of rheumatoid arthritis patients treated with itolizumab.A clinical exploratory study with itolizumab, an anti-CD6 monoclonal antibody, in patients with rheumatoid arthritis.Human endogenous retrovirus type W (HERV-W) in schizophrenia: a new avenue of research at the gene-environment interface.Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases.CD6 gene polymorphism rs17824933 is associated with multiple sclerosis in Indian population.CD318 is a ligand for CD6.CD6 as a potential target for treating multiple sclerosisAssociation Study of Tumor Necrosis Factor Receptor 1 (TNFR1) Gene Polymorphisms with Schizophrenia in the Polish Population.Targeting CD6 for the treatment of experimental autoimmune uveitis.
P2860

Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain.

Item
http://www.wikidata.org/entity/Q44608425
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain.
@en
Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain.
@nl
type
label
Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain.
@en
Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain.
@nl
prefLabel
Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain.
@en
Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain
@en
P2093
P304
P31
P356
10.1016/J.JNEUROIM.2010.03.020
P433
P478
P50
P577
P698
P921